Sirtex Medical Inc
Pharmaceutical & medical device company payment data from CMS Open Payments.
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $8.8M | 3,050 | 33.2% |
| Unspecified | $7.5M | 852 | 28.3% |
| Consulting Fee | $4.6M | 1,656 | 17.4% |
| Honoraria | $2.2M | 962 | 8.2% |
| Travel and Lodging | $1.9M | 11,172 | 7.2% |
| Food and Beverage | $1.5M | 24,432 | 5.7% |
| Education | $1,695 | 3 | 0.0% |
| Gift | $385.98 | 2 | 0.0% |
Payments by Type
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| DOORwaY Study | $2.3M | 0 | 227 |
| DOORwaY90 | $1.0M | 0 | 150 |
| RESiN Registry | $990,398 | 0 | 138 |
| Radiation-Emitting SIR-Spheres in Non-resectable (RESIN) Liver Tumor Patient Study | $883,298 | 0 | 266 |
| MIDwaY90 | $528,031 | 0 | 25 |
| Low-dose Y90 Treatment Planning for HCC | $271,750 | 0 | 5 |
| CapTemY90 for Grade 2 NET Liver Metastases (CapTemY90) | $241,480 | 0 | 3 |
| CapTem Y90 for Grade 2 NET Liver Metastases | $225,850 | 0 | 4 |
| RESIN microsphere dosimetry: assessment of tumor dosimetry from lobar and segmental treatments using FLEX dose vs treatment on the day of calibration | $108,663 | 0 | 3 |
| SIRT With Tremelimumab and Durvalumab for Resectable HCC | $100,000 | 0 | 4 |
| US Medical RESiN-Misc | $97,215 | 0 | 7 |
| Characterization & Outcomes of Resin Radiation Segmentectomy for Liver | $93,716 | 0 | 1 |
| Preoperative Y-90 Radioembolization for Tumor Control and Future Liver Remnant Hypertrophy in Patients With Colorectal Liver Metastases | $81,000 | 0 | 3 |
| Radioembolization of Metastatic Breast Cancer to the Liver as a 2nd/3rd Line Therapy | $70,000 | 0 | 1 |
| Optimization of Antitumoral Microenvironment of Hepatocellular carcinoma (HCC) with Yttrium-90 Trans-Arterial radioembolization (TARE) for Synergistic Effect with Immunotherapy | $66,768 | 0 | 1 |
| Y-90 With Durvalumab/Gem/Cis in Intrahepatic Cholangio | $55,833 | 0 | 2 |
| Streamlined Resin Y90 Radiation Segmentectomy for Small HCC: One & Done Trial | $52,734 | 0 | 2 |
| Phase I Study of TAS-102 & Radioemboilzation with 90Y Resin | $40,000 | 0 | 1 |
| SIR SPHERES | $15,660 | 0 | 2 |
| Evaluating the effects of segmental/super selective treatment utilizing flex-dosing in treating unresectable HCC with Y90 SIR-Spheres resin microspheres (Super selective flex-dosing) | $5,500 | 0 | 1 |
| SIRT Followed by CIS-GEM Chemotherapy Versus CIS-GEM Chemotherapy Alone as 1st Line Treatment of Patients With Unresectable Intrahepatic Cholangiocarcinoma (SIRCCA) | $3,664 | 0 | 2 |
Payments by Medical Specialty
Top Paid Doctors
| Doctor | Specialty | Location | Total | 2024 |
|---|---|---|---|---|
| Dr. Ripal Gandhi, M.d, M.D | Vascular & Interventional Radiology | Miami, FL | $1.8M | $0 |
| Dr. Michael Cohn, M.d, M.D | Vascular & Interventional Radiology | Hollywood, FL | $1.3M | $0 |
| Michael Doherty, Md, MD | Vascular & Interventional Radiology | Jackson, TN | $784,976 | $0 |
| Dr. Suvranu Ganguli, M.d, M.D | Vascular & Interventional Radiology | Boston, MA | $694,955 | $0 |
| Dr. Justin Lee, M.d, M.D | Vascular & Interventional Radiology | Tampa, FL | $666,008 | $0 |
| Jayson Brower, Md, MD | Diagnostic Radiology | Spokane, WA | $623,399 | $0 |
| Dr. Fred Moeslein, Md, Phd, MD, PHD | Vascular & Interventional Radiology | Columbus, OH | $595,779 | $0 |
| Mark Westcott, Md, MD | Diagnostic Radiology | New York, NY | $557,073 | $0 |
| Alexander Kim, Md, MD | Vascular & Interventional Radiology | Oxon Hill, MD | $523,996 | $0 |
| Edward Lee, Md, MD | Diagnostic Radiology | Los Angeles, CA | $463,869 | $0 |
| Nima Kokabi, Md, MD | Vascular & Interventional Radiology | Atlanta, GA | $463,584 | $0 |
| Brandon Martinez, Md, MD | Diagnostic Radiology | Fishers, IN | $378,825 | $0 |
| Dr. Navid Eghbalieh, M.d, M.D | Vascular & Interventional Radiology | Los Angeles, CA | $353,953 | $0 |
| Aaron Kovaleski, M.d, M.D | Vascular & Interventional Radiology | Lone Tree, CO | $331,808 | $0 |
| Eric Reiner, Do, DO | Diagnostic Radiology | Danbury, CT | $318,720 | $0 |
| Sabina Amin, Md, MD | Diagnostic Radiology | Camden, NJ | $303,898 | $0 |
| Dr. Zachary Collins, M.d, M.D | Vascular & Interventional Radiology | Kansas City, KS | $292,779 | $0 |
| Randall Smith, Md, MD | Vascular & Interventional Radiology | Grand Forks, ND | $259,381 | $0 |
| Christopher Loh, Md, MD | Neuroradiology | Santa Monica, CA | $253,196 | $0 |
| Aneesa Majid, Md, MD | Diagnostic Radiology | Elkhart, IN | $251,495 | $0 |
| Dr. Guillermo Gonzalez-Araiza, Md, MD | Diagnostic Radiology | Saint Louis, MO | $246,270 | $0 |
| Steve Chen, Md, MD | Vascular & Interventional Radiology | Seattle, WA | $245,594 | $0 |
| Dr. Sasidhar Yallampalli, M.d, M.D | Diagnostic Radiology | Houston, TX | $245,137 | $0 |
| Dr. Navesh Sharma, D.o., Ph.d, D.O., PH.D | Radiation Oncology | York, PA | $237,465 | $0 |
| Michael Jaimes, M.d, M.D | Vascular & Interventional Radiology | Austin, TX | $232,325 | $0 |
Top Products
- SIR-Spheres Microspheres $26.1M
- LAVA LES (Liquid Embolic System) $257,954
Associated Products (2)
- SIR-Spheres Microspheres $26.1M
- LAVA LES (Liquid Embolic System) $257,954
Payment Categories
- Food & Beverage $1.5M
- Consulting $4.6M
- Travel & Lodging $1.9M
- Research $7.5M
About Sirtex Medical Inc
Sirtex Medical Inc has made $26.4M in payments to 5,965 healthcare providers, recorded across 42,129 transactions in the CMS Open Payments database. In 2024, the company paid $4.2M. The top product by payment volume is SIR-Spheres Microspheres ($26.1M).
Payments were distributed across 120 medical specialties. The top specialty by payment amount is Vascular & Interventional Radiology ($10.7M to 861 doctors).
Payment categories include: Food & Beverage ($1.5M), Consulting ($4.6M), Research ($7.5M), Travel & Lodging ($1.9M).
Sirtex Medical Inc is associated with 2 products in the CMS Open Payments database.